14 Results for "

2905

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "2905" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-N2905
CAS No.: 56121-42-7
Synonyms: Asperglaucide
Aurantiamide acetate (TMC-58A) is a selective and orally active cathepsin inhibitor isolated from Portulaca oleracea L. Aurantiamide acetate has anti-inflammatory activities and can be used for the study of inflammatory diseases .
loading...
    loading...
Cat. No.: HY-Z2905R
CAS No.: 1033803-59-6
Target:  

Reference Standards

2-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol (Duloxetine Impurity) (Standard) is the analytical standard of 2-(3-(Methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol (Duloxetine Impurity). This product is intended for research and analytical applications.
loading...
    loading...
Cat. No.: HY-Z2905
CAS No.: 1033803-59-6
Synonyms: Duloxetine impurity E
Target:  

Drug Intermediate

Research Areas:  

Others

Duloxetine impurity 7 (Duloxetine impurity E) is an impurity of Duloxetine.
loading...
    loading...
Cat. No.: HY-Z2905A
CAS No.: 1033719-36-6
Synonyms: Duloxetine impurity E hydrochloride
Target:  

Drug Intermediate

Research Areas:  

Others

Duloxetine impurity 7 hydrochloride (Duloxetine impurity E hydrochloride) is an impurity of Duloxetine hydrochloride.
loading...
    loading...
Cat. No.: HY-122015
CAS No.: 792184-90-8
Purity:  99.77%
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

ASP2905 is an orally active potassium channel Kv12.2 inhibitor encoded by the Kcnh3/BEC1 gene. ASP2905 can cross the blood-brain barrier and has antipsychotic activities .
loading...
    loading...
Cat. No.: HY-110369
CAS No.: 3033550-04-5
Synonyms: a,β-Methylene-2-thio-UDP trisodium
Target:  

P2Y Receptor

Research Areas:  

Inflammation/Immunology

MRS2905 (α,β-Methylene-2-thio-UDP) trisodium is a selective P2Y14R agonist with an EC50 of 0.92 nM. MRS2905 trisodium is inactive at the UDP-activated P2Y6 receptor, and at other P2Y receptors .
loading...
    loading...
Cat. No.: HY-153577
CAS No.: 23983-05-3
Target:  

Transthyretin (TTR)

Research Areas:  

Neurological Disease

WT-TTR inhibitor 1 (Compound 21) is a wild-type Transthyretin (WT-TTR) inhibitor with 29.05% inhibition at 100 μM .
loading...
    loading...
Cat. No.: HY-RS16431
Research Areas:  

Others

GRIN2C Human Pre-designed siRNA Set A contains three designed siRNAs for GRIN2C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-103510
CAS No.: 207306-50-1
Purity:  99.7%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

TB-21007 is a selective and brain penetrant α5 subunit-containing GABAA receptor inverse agonist with Kis of 1.6 nM, 20 nM, 16 nM, and 20 nM for α5, α1, α2 and α3 subtypes, respectively. TB-21007 enhances cognition in rats .
loading...
    loading...
Cat. No.: HY-P83160
Synonyms: EAB1

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P83160A
Synonyms: EAB1

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-L173
2,905 compounds

Ovarian cancer is the most common cause of death in female genital malignancies, with the highest mortality rate in female genital malignancies. It is characterized by difficulty in detection in the early stage of the disease, high recurrence rate and poor prognosis. In fact, ovarian cancer includes many pathologic types. It is usually divided into epithelial ovarian cancer, malignant germ cell tumors and sex cord stromal tumors, of which epithelial ovarian cancer is the most dominant form. Clinical treatment of ovarian cancer prioritizes surgery combined with paclitaxel chemotherapy. However, due to the spread and drug resistance of tumor cells, the recurrence of ovarian cancer is high. In this case, combined with traditional methods, the development of new therapeutic agents can help to improve the treatment effect of ovarian cancer.

MCE designs a unique collection of 2,905 compounds with definite or potential anti-ovarian cancer activity, which mainly targeting the main targets of ovarian cancer such as PARP, ATM/ATR, VEGFR and HIF/HIF Prolyl-Hydroxylase, etc. It is an essential tool for development and research of anti-ovarian compounds.

Cat. No.: HY-P71695
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: speA; b2938; JW2905; Biosynthetic arginine decarboxylase; ADC; EC 4.1.1.19
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P81866
Synonyms: IKBKE; IKKE; IKKI; KIAA0151; Inhibitor of nuclear factor kappa-B kinase subunit epsilon; I-kappa-B kinase epsilon; IKK-E; IKK-epsilon; IkBKE; Inducible I kappa-B kinase; IKK-i

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, FC

Reactivity:  

Human

loading...
    loading...
  • 1